FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016223527> ?p ?o ?g. }

• W2016223527 endingPage "20" @default.
• W2016223527 startingPage "412" @default.
• W2016223527 abstract "The prevalence of autoantibodies in multiple sclerosis (MS) patients and their clinical associations differ between various studies. This study investigated antiphospholipid and antinuclear antibodies in 85 patients with multiple sclerosis (MS) and clinically isolated syndrome (CIS) with regard to their association with demographic features, MS specific clinical features and symptoms of connective tissue diseases. Autoantibodies tested included antinuclear antibodies (ANA) with their specificities and anticardiolipin (aCL) and anti-beta-2-glycoprotein I (anti-β2GPI) antibodies. Antinuclear antibodies were more prevalent in MS patients than in controls (63.5% vs. 3.3%; p < 0.01) and in 19% of patients specific antinuclear antibodies were detected. Anti-β2GPI IgM antibodies were more frequent in MS patients than in the control group (20% vs. 3.3%; p < 0.05). The frequency of anticardiolipin antibodies did not differ between MS patients and controls. MS patients seropositive for ANA and extractable nuclear antigens (ENA) had significantly shorter disease duration than seronegative patients (p < 0.05) and a lower disability score (Expanded Disability Status Score; EDSS) (p < 0.05). Anti-β2GPI antibodies were more frequent in patients with secondary progressive MS (SP-MS) and specific ANA antibodies were more frequent in patients with clinically isolated syndrome (CIS) (p < 0.05). The presence of autoantibodies was not associated with the predominant site of neurological involvement or the clinical features of connective tissue diseases." @default.
• W2016223527 created "2016-06-24" @default.
• W2016223527 creator A5001116231 @default.
• W2016223527 creator A5001556029 @default.
• W2016223527 creator A5007364793 @default.
• W2016223527 creator A5017404016 @default.
• W2016223527 creator A5032875324 @default.
• W2016223527 creator A5058937664 @default.
• W2016223527 creator A5078401054 @default.
• W2016223527 creator A5088235093 @default.
• W2016223527 date "2012-04-01" @default.
• W2016223527 modified "2023-09-30" @default.
• W2016223527 title "Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis." @default.
• W2016223527 cites W1963553004 @default.
• W2016223527 cites W1967553728 @default.
• W2016223527 cites W1982309500 @default.
• W2016223527 cites W1987057401 @default.
• W2016223527 cites W1988361076 @default.
• W2016223527 cites W1990903507 @default.
• W2016223527 cites W2003551374 @default.
• W2016223527 cites W2011067101 @default.
• W2016223527 cites W2022396145 @default.
• W2016223527 cites W2024003347 @default.
• W2016223527 cites W2028878435 @default.
• W2016223527 cites W2049302669 @default.
• W2016223527 cites W2055847238 @default.
• W2016223527 cites W2068469174 @default.
• W2016223527 cites W2090907841 @default.
• W2016223527 cites W2091434271 @default.
• W2016223527 cites W2092731800 @default.
• W2016223527 cites W2100088477 @default.
• W2016223527 cites W2105490558 @default.
• W2016223527 cites W2111992141 @default.
• W2016223527 cites W2112165124 @default.
• W2016223527 cites W2112935184 @default.
• W2016223527 cites W2119271428 @default.
• W2016223527 cites W2122626653 @default.
• W2016223527 cites W2136281086 @default.
• W2016223527 cites W2139344244 @default.
• W2016223527 cites W2141111992 @default.
• W2016223527 cites W2155704861 @default.
• W2016223527 cites W2156547159 @default.
• W2016223527 doi "https://doi.org/10.1177/0961203311427550" @default.
• W2016223527 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22074845" @default.
• W2016223527 hasPublicationYear "2012" @default.
• W2016223527 type Work @default.
• W2016223527 sameAs 2016223527 @default.
• W2016223527 citedByCount "48" @default.
• W2016223527 countsByYear W20162235272012 @default.
• W2016223527 countsByYear W20162235272013 @default.
• W2016223527 countsByYear W20162235272014 @default.
• W2016223527 countsByYear W20162235272015 @default.
• W2016223527 countsByYear W20162235272016 @default.
• W2016223527 countsByYear W20162235272017 @default.
• W2016223527 countsByYear W20162235272019 @default.
• W2016223527 countsByYear W20162235272020 @default.
• W2016223527 countsByYear W20162235272022 @default.
• W2016223527 countsByYear W20162235272023 @default.
• W2016223527 crossrefType "journal-article" @default.
• W2016223527 hasAuthorship W2016223527A5001116231 @default.
• W2016223527 hasAuthorship W2016223527A5001556029 @default.
• W2016223527 hasAuthorship W2016223527A5007364793 @default.
• W2016223527 hasAuthorship W2016223527A5017404016 @default.
• W2016223527 hasAuthorship W2016223527A5032875324 @default.
• W2016223527 hasAuthorship W2016223527A5058937664 @default.
• W2016223527 hasAuthorship W2016223527A5078401054 @default.
• W2016223527 hasAuthorship W2016223527A5088235093 @default.
• W2016223527 hasConcept C126322002 @default.
• W2016223527 hasConcept C142724271 @default.
• W2016223527 hasConcept C149443304 @default.
• W2016223527 hasConcept C159654299 @default.
• W2016223527 hasConcept C163764329 @default.
• W2016223527 hasConcept C203014093 @default.
• W2016223527 hasConcept C2776151748 @default.
• W2016223527 hasConcept C2776670291 @default.
• W2016223527 hasConcept C2776874634 @default.
• W2016223527 hasConcept C2778962941 @default.
• W2016223527 hasConcept C2779075594 @default.
• W2016223527 hasConcept C2780022809 @default.
• W2016223527 hasConcept C2780640218 @default.
• W2016223527 hasConcept C63363279 @default.
• W2016223527 hasConcept C71924100 @default.
• W2016223527 hasConcept C90924648 @default.
• W2016223527 hasConceptScore W2016223527C126322002 @default.
• W2016223527 hasConceptScore W2016223527C142724271 @default.
• W2016223527 hasConceptScore W2016223527C149443304 @default.
• W2016223527 hasConceptScore W2016223527C159654299 @default.
• W2016223527 hasConceptScore W2016223527C163764329 @default.
• W2016223527 hasConceptScore W2016223527C203014093 @default.
• W2016223527 hasConceptScore W2016223527C2776151748 @default.
• W2016223527 hasConceptScore W2016223527C2776670291 @default.
• W2016223527 hasConceptScore W2016223527C2776874634 @default.
• W2016223527 hasConceptScore W2016223527C2778962941 @default.
• W2016223527 hasConceptScore W2016223527C2779075594 @default.
• W2016223527 hasConceptScore W2016223527C2780022809 @default.
• W2016223527 hasConceptScore W2016223527C2780640218 @default.
• W2016223527 hasConceptScore W2016223527C63363279 @default.
• W2016223527 hasConceptScore W2016223527C71924100 @default.

• next